2015
DOI: 10.13052/ijts2246-8765.2015.003
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic immunomodulation with mesenchymal stromal cells: the need for in vivo clues

Abstract: Mesenchymal stem/stromal cells are effective therapeutic agents for a variety of pathological conditions. However, the molecular mechanisms underlying their action remain largely unknown and biased by in vitro studies. In this concise review we have described recent advances in MSC therapeutics based on in vivo observations. We have also discussed the possibility of using engineering approaches to improve and facilitate deciphering MSC functions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 91 publications
0
2
0
Order By: Relevance
“…These features have often been used to explain their "immune privileged" status in allogeneic hosts. Furthermore, BM-MSCs have been shown to inhibit dendritic cell maturation [44], B cell [45] and T cell proliferation [46] and differentiation [47], impair natural killer cell activity [48], as well as support the generation of suppressive immune cells such as: regulatory T cells (Tregs) [43,49], myeloid derived suppressor cells (MDSCs) and tolerogenic dendritic cells (tDCs) [50]. Combination of many soluble factors are meritorious for immunosuppressive activity of BM-MSCs, such as: indoleamine 2,3-dioxygenase (IDO), inducible nitric oxide synthase (iNOS), cyclooxygenases (COX), metabolite prostaglandin E2 (PGE2), tumor necrosis factor α-induced protein 6 (TSG6), transforming growth factor β (TGF-β), soluble form of HLA-G5 [35,44].…”
Section: Immunosuppressive Properties Of Bm-mscsmentioning
confidence: 99%
“…These features have often been used to explain their "immune privileged" status in allogeneic hosts. Furthermore, BM-MSCs have been shown to inhibit dendritic cell maturation [44], B cell [45] and T cell proliferation [46] and differentiation [47], impair natural killer cell activity [48], as well as support the generation of suppressive immune cells such as: regulatory T cells (Tregs) [43,49], myeloid derived suppressor cells (MDSCs) and tolerogenic dendritic cells (tDCs) [50]. Combination of many soluble factors are meritorious for immunosuppressive activity of BM-MSCs, such as: indoleamine 2,3-dioxygenase (IDO), inducible nitric oxide synthase (iNOS), cyclooxygenases (COX), metabolite prostaglandin E2 (PGE2), tumor necrosis factor α-induced protein 6 (TSG6), transforming growth factor β (TGF-β), soluble form of HLA-G5 [35,44].…”
Section: Immunosuppressive Properties Of Bm-mscsmentioning
confidence: 99%
“…These constructions can be classified into two main groups: with and without cells [2]. MSCs can be useful in many pathological conditions, though the mechanism of their action is still unknown [6]. Some problems by these con-structions are slow and insufficient vascularization of large ones [7].…”
Section: Introductionmentioning
confidence: 99%